H. SAVLI Et Al. , "Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study," TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, pp.206-212, 2015
SAVLI, H. Et Al. 2015. Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study. TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3 , 206-212.
SAVLI, H., Galimberti, S., Sunnetci, D., Canestraro, M., Palumbo, G., Nagy, B., ... Di Raimondo, F.(2015). Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study. TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, 206-212.
SAVLI, HAKAN Et Al. "Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study," TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, 206-212, 2015
SAVLI, HAKAN Et Al. "Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study." TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, pp.206-212, 2015
SAVLI, H. Et Al. (2015) . "Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study." TURKISH JOURNAL OF HEMATOLOGY , vol.32, no.3, pp.206-212.
@article{article, author={HAKAN SAVLI Et Al. }, title={Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study}, journal={TURKISH JOURNAL OF HEMATOLOGY}, year=2015, pages={206-212} }